7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
                       
      cash flows from operating activities:
                       
      net income
    1,525,000 -1,968,000 4,743,000 6,577,000 -1,371,000 -12,574,000 -4,683,000 -12,456,000 -48,965,000 4,706,000 1,358,000 9,174,000 3,936,000 -589,000 2,210,000 -9,699,000 -1,762,000 -2,857,000 1,052,000 
      adjustments to reconcile net income to net cash from operating activities:
                       
      depreciation and amortization
    18,626,000                   
      amortization of debt issuance costs
    143,000 145,000 144,000 144,000 142,000 369,000 380,000 381,000 381,000 382,000 383,000 384,000 385,000 385,000 386,000 387,000 397,000 369,000 378,000 
      benefit from credit losses
    287,000 79,000 322,000     632,000 224,000           
      equity-based compensation expense
    9,574,000 8,245,000 7,070,000 7,731,000 8,187,000 9,783,000 9,073,000 7,502,000 8,645,000 3,610,000 8,543,000 6,527,000 6,804,000 9,501,000 7,513,000 8,637,000 8,165,000 7,530,000 5,151,000 
      change in fair value of contingent considerations
    2,689,000 -5,722,000 -179,000 -3,000 2,431,000 2,783,000 2,878,000 12,802,000 8,757,000           
      deferred income taxes
    -5,486,000 -12,471,000 10,502,000 -69,000 789,000 -8,586,000 -4,829,000 2,009,000 -8,295,000 -8,713,000 -1,524,000 -8,302,000 2,398,000 -4,892,000 -715,000 -2,980,000 3,767,000 -1,983,000 12,000 
      changes in assets and liabilities:
                       
      accounts receivable
    7,912,000 -3,263,000 8,736,000 -5,252,000 -4,367,000 -10,241,000 3,635,000 -6,289,000 6,713,000 -919,000 647,000 -7,114,000 -2,189,000 -2,462,000 -3,244,000 -3,918,000 -6,768,000 622,000 -2,000 
      prepaid expenses and other assets
    -4,360,000 4,301,000 1,807,000  -2,168,000 273,000 -578,000  -409,000    -377,000 3,933,000 653,000 6,089,000    
      accounts payable, accrued expenses, and other liabilities
    7,316,000 13,891,000 -27,783,000  -1,469,000 6,520,000 -14,825,000             
      deferred revenues
    -5,942,000 -4,213,000 -5,448,000  -2,784,000 3,933,000 -3,271,000             
      other operating activities
    30,000 -1,176,000 389,000                
      net cash from operating activities
    32,314,000 17,842,000 17,352,000 49,369,000 16,987,000 9,814,000 4,296,000 23,326,000 31,414,000 18,058,000 9,957,000 35,485,000 23,996,000 23,259,000 9,803,000 20,831,000 20,001,000 14,622,000 4,934,000 
      cash flows from investing activities:
                       
      capital expenditures
    -221,000 64,000 -600,000 -415,000 -164,000 -427,000 -619,000 -878,000 -311,000 -271,000 -317,000 -181,000 -390,000 -353,000 -506,000 -148,000 -484,000 -289,000 -222,000 
      free cash flows
    32,093,000 17,906,000 16,752,000 48,954,000 16,823,000 9,387,000 3,677,000 22,448,000 31,103,000 17,787,000 9,640,000 35,304,000 23,606,000 22,906,000 9,297,000 20,683,000 19,517,000 14,333,000 4,712,000 
      capitalized software development costs
    -6,571,000 -7,025,000 -5,174,000 -5,421,000 -5,344,000 -5,692,000 -2,959,000             
      net cash from investing activities
    -6,792,000 -6,961,000 -5,774,000 -97,163,000 -5,508,000 -6,119,000 -3,578,000 -61,047,000 -4,041,000 -11,731,000 -2,731,000 -12,599,000 -3,324,000 -3,238,000 -8,676,000 -249,323,000 -2,600,000 -14,541,000 -3,458,000 
      cash flows from financing activities:
                       
      proceeds from borrowings on term loan debt
                     
      payment of debt issuance costs
                 -11,000   
      payments on long-term debt
    -750,000 -750,000 -750,000                 
      common stock repurchase program
    -13,674,000                   
      payments for business acquisition related contingent consideration
    -13,230,000 -4,730,000 -1,777,000 -8,649,000             
      payment of taxes on shares withheld for employee taxes
    -59,000 -4,944,000 -16,000  -125,000 -7,067,000 -943,000  -170,000    -515,000 -2,264,000 -48,000     
      net cash from financing activities
    -14,483,000 -30,694,000 -13,996,000 -1,303,000 -5,605,000 -3,755,000 -10,347,000 -1,252,000      -3,531,000 -1,520,000 -3,644,000 132,200,000 -4,310,000 -855,000 
      effect of foreign exchange rate on cash and cash equivalents
    -594,000 2,993,000 2,321,000                 
      net decrease in cash and cash equivalents
    10,445,000                   
      cash and cash equivalents, and restricted cash, at beginning of period
       234,951,000  239,688,000  186,624,000    
      cash and cash equivalents, and restricted cash, at end of period
    10,445,000    8,424,000 -177,000 224,776,000  24,102,000 972,000 247,238,000  15,533,000 13,190,000 185,060,000  148,363,000   
      supplemental disclosures of cash flow information
                       
      cash paid for interest
    1,156,000 4,652,000 4,648,000 11,566,000 -1,515,000 7,291,000 5,395,000 5,421,000 5,413,000 3,059,000 5,196,000 4,958,000 4,842,000 3,921,000 3,547,000 3,498,000 3,557,000 3,562,000 3,552,000 
      cash paid for taxes
    2,730,000 5,351,000 688,000 3,028,000 3,131,000 4,859,000 3,640,000 6,955,000 3,331,000 8,517,000 517,000 2,357,000 2,226,000 2,789,000 2,769,000 1,851,000 2,324,000 2,776,000 1,644,000 
      supplemental schedule of noncash investing and financing activities
                       
      stock issuance or establish liabilities related to business acquisition contingent consideration
    5,670,000                
      adjustments to reconcile net income (loss ) to net cash from operating activities:
                       
      depreciation and amortization of property and equipment
      873,000 672,000 439,000 451,000 432,000 413,000 367,000 361,000 411,000 410,000 417,000 422,000 482,000 448,000 533,000 552,000 602,000 
      amortization of intangible assets
      17,741,000 17,544,000 16,353,000 16,146,000 15,996,000 14,420,000 13,813,000 13,173,000 13,113,000 12,732,000 12,846,000 12,711,000 12,450,000 12,545,000 10,208,000 10,125,000 10,102,000 
      goodwill impairment
                      
      net decrease in cash and cash equivalents, and restricted cash
      -97,000                 
      cash and cash equivalents at beginning of period
      179,183,000                 
      cash and cash equivalents at end of period
      179,086,000                 
      changes in assets and liabilities
                       
      prepaid and other assets
              559,000         
      accounts payable and accrued expenses, and other liabilities
                       
      deferred revenue
           7,006,000 -4,895,000 -1,049,000 -1,034,000 11,257,000 -4,913,000 630,000 2,556,000   -550,000 -507,000 
      investment in intangible assets
           -54,000         
      business acquisitions, net of cash acquired
           -56,678,000   -9,425,000 100,000 -5,983,000 -246,906,000 -12,070,000 -2,044,000 
      payments on long-term debt and finance lease obligations
       -750,000 -750,000 -755,000 -755,000 -755,000 -755,000 -780,000 -830,000 -829,000 -828,000 -826,000     
      payments on financing component of interest rate swap
               -3,000 -439,000 -646,000 -879,000    
      payment of taxes on shares and units withheld for employee taxes
              -70,000         
      effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash
                      -191,000 
      net increase in cash, cash equivalents, and restricted cash
                      430,000 
      cash, cash equivalents, and restricted cash, at beginning of year
                       
      cash, cash equivalents, and restricted cash, at end of year
                       
      contingent liabilities established in connection with business acquisition
           10,518,000           
      stock issuance related to business acquisition contingent consideration
                       
      (recovery of) benefit from credit losses
        -414,000 748,000 59,000    -168,000   183,000 34,000     
      effect of foreign exchange rate on cash and cash equivalents, and restricted cash
        2,550,000               
      net increase in cash and cash equivalents, and restricted cash
        8,424,000 -177,000 -10,175,000  24,102,000 972,000 7,550,000  15,533,000 13,190,000 -1,564,000  148,363,000   
      loss on extinguishing debt
                       
      loss on retirement of assets
           36,000 25,000 4,000 113,000 49,000 2,000 5,000 47,000 22,000   
      lease abandonment expense
         29,000            
      effect of foreign exchange rate changes on cash and cash equivalents, and restricted cash
          -546,000  -2,346,000 1,065,000 1,174,000  -3,795,000 -3,300,000 -1,171,000  -1,238,000   
      issuance of common stock for business acquisition related contingent consideration
          3,707,000             
      unrealized loss on derivative
                       
      proceeds from issuance of common stock, net of underwriters' discounts and commissions
                       
      proceeds from borrowings on long-term debt
                     
      payment of deferred offering costs
                       
      operating right-of-use assets recognized upon adoption of asc 842
                       
      operating lease liability recognized upon adoption of asc 842
                       
      common shares issued in connections with the pinnacle acquisition
                       
      accounts payable and accrued expenses
            6,785,000 5,853,000 -14,196,000       -2,668,000 -11,180,000 
      other liabilities
                       
      capitalized development costs
            -3,730,000 -3,910,000 -2,360,000  -2,934,000 -2,985,000 -2,187,000 -2,269,000 -2,116,000 -2,182,000 -1,192,000 
      supplemental schedule of non-cash investing and financing activities
                       
      change in other liabilities
              600,000         
      net cash used by financing activities
             -6,420,000 -850,000         
      change in fair value of contingent consideration
              1,261,000         
      ​
                       
      capital contributions
                       
      unit repurchase
                       
      proceeds from line of credit
                       
      payments on line of credit
                       
      property and equipment controlled through capital lease obligations
                       
      deferred offering costs, accrued but not paid
                       
      unrealized loss on interest rate swap
                    -640,000   
      accounts payable and other liabilities
                4,530,000 3,896,000 -11,830,000     
      other current liabilities
                441,000 -737,000 -792,000     
      changes in operating lease assets and liabilities
                -582,000 276,000 95,000     
      net proceeds from public offering of common stock
                       
      net cash (used) provided by financing activities
                       
      liabilities assumed in connection with business acquisition
                    991,000 921,000 
      changes in assets and liabilities, net of acquisitions:
                       
      cash, cash equivalents, and restricted cash, at beginning of period
                      273,291,000 
      cash, cash equivalents, and restricted cash, at end of period
                      273,721,000 
      benefit from doubtful accounts
                       
      payments on long-term debt and capital lease obligations
                    -824,000 -1,468,000 -855,000 
      proceeds from borrowings from affiliate
                       
      capital lease
                       
      recovery of doubtful accounts
                     -60,000 -1,000 
      prepaid expenses and other current assets
                     870,000 -673,000 
      property and equipment controlled through new capital leases
                       
      (recovery of) benefit from doubtful accounts
                       
      equity compensation expense
                       
      proceeds from issuance of common stock upon initial public offering, net of underwriters’ discounts and commissions
                       
      payments of deferred offering costs
                       
      payment of contingent consideration obligations
                       
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.